C. S. Asbill

879 total citations
10 papers, 548 citations indexed

About

C. S. Asbill is a scholar working on Pharmaceutical Science, Dermatology and Pharmacology. According to data from OpenAlex, C. S. Asbill has authored 10 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 5 papers in Dermatology and 2 papers in Pharmacology. Recurrent topics in C. S. Asbill's work include Advancements in Transdermal Drug Delivery (7 papers), Dermatology and Skin Diseases (5 papers) and Advanced Drug Delivery Systems (3 papers). C. S. Asbill is often cited by papers focused on Advancements in Transdermal Drug Delivery (7 papers), Dermatology and Skin Diseases (5 papers) and Advanced Drug Delivery Systems (3 papers). C. S. Asbill collaborates with scholars based in United States. C. S. Asbill's co-authors include Bozena Michniak, Ayman El‐Kattan, Kim E. Creek, Philip W. Wertz, Sam Haidar, J. Walter Sowell, Robert A. Latour and Andrew Webster and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

C. S. Asbill

10 papers receiving 517 citations

Peers

C. S. Asbill

PS

DERMA

FS

MB

PHEOH

Dongsheng Mou China

Anika Haq United States

Hagen Trommer Germany

Inayat Bashir Pathan India

Christophe Herkenne Switzerland

Monika Kopečná Czechia

Punit B. Parejiya India

Thasleem Moolakkadath India

Krishna Chaitanya Telaprolu Australia

Annie Hoelgaard Denmark

Dongsheng Mou China

C. S. Asbill

486 ×1.2

PS

119 ×0.6

DERMA

107 ×1.0

FS

80 ×1.0

MB

34 ×0.6

PHEOH

Citations per year, relative to C. S. Asbill C. S. Asbill (= 1×) peers Dongsheng Mou

Countries citing papers authored by C. S. Asbill

Since Specialization

Citations

This map shows the geographic impact of C. S. Asbill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. S. Asbill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. S. Asbill more than expected).

Fields of papers citing papers by C. S. Asbill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. S. Asbill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. S. Asbill. The network helps show where C. S. Asbill may publish in the future.

Co-authorship network of co-authors of C. S. Asbill

This figure shows the co-authorship network connecting the top 25 collaborators of C. S. Asbill. A scholar is included among the top collaborators of C. S. Asbill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. S. Asbill. C. S. Asbill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Asbill, C. S., et al.. (2022). Traditional Lecture versus Case-Based Learning in a Therapeutic Drug Monitoring Course within an Integrated Pharmacy Curriculum. SHILAP Revista de lepidopterología. 13(1). 19–19. 2 indexed citations

2.

Asbill, C. S., et al.. (2015). Isoniazid release from suppositories compounded with selected bases.. PubMed. 11(5). 433–7. 1 indexed citations

3.

Asbill, C. S., et al.. (2007). Using the Humanities to Strengthen the Concept of Professionalism Among First-professional Year Pharmacy Students. American Journal of Pharmaceutical Education. 71(2). 28–28. 34 indexed citations

4.

El‐Kattan, Ayman, et al.. (2001). Evaluation of derivatives of 3-(2-oxo-1-pyrrolidine) hexahydro-1H-azepine-2-one as dermal penetration enhancers: side chain length variation and molecular modeling. Journal of Controlled Release. 73(2-3). 183–196. 16 indexed citations

5.

El‐Kattan, Ayman, et al.. (2001). The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. International Journal of Pharmaceutics. 215(1-2). 229–240. 128 indexed citations

6.

Asbill, C. S., et al.. (2000). Evaluation of a Human Bio-Engineered Skin Equivalent for Drug Permeation Studies. Pharmaceutical Research. 17(9). 1092–1097. 56 indexed citations

7.

El‐Kattan, Ayman, C. S. Asbill, & Sam Haidar. (2000). Transdermal testing: practical aspects and methods. PubMed. 3(12). 426–430. 19 indexed citations

8.

El‐Kattan, Ayman, C. S. Asbill, & Bozena Michniak. (2000). The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. International Journal of Pharmaceutics. 198(2). 179–189. 109 indexed citations

9.

Asbill, C. S. & Bozena Michniak. (2000). Percutaneous penetration enhancers: local versus transdermal activity. PubMed. 3(1). 36–41. 99 indexed citations

10.

Asbill, C. S., Ayman El‐Kattan, & Bozena Michniak. (2000). Enhancement of Transdermal Drug Delivery: Chemical and Physical Approaches. Critical Reviews in Therapeutic Drug Carrier Systems. 17(6). 64–64. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact